BioRestorative Therapies Inc (BRTX)

[West2]

$BRTX Recently, there has been a shift towards providing access to non-FDA-approved stem cell therapies for patients suffering from numerous musculoskeletal conditions, particularly back pain. Although not covered by insurance, states such as Utah, Wyoming, Texas, and Florida have instituted state laws that allow providers to offer therapies, such as BRTX-100, to patients. We intend to seek strategic and commercial partnerships within these states, which would allow us to potentially commercialize BRTX-100 prior to full BLA approval.